FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014769241> ?p ?o ?g. }

• W2014769241 endingPage "359" @default.
• W2014769241 startingPage "359" @default.
• W2014769241 abstract "<b>Background:</b> Kligman's triple combination formula has been one of the most popular treatment options in melasma over the last three decades. The original Kligman's formula has been modified in many ways over the years and the most recent modification that has been introduced is a triple combination of 2% hydroquinone, 0.025% tretinoin, and 1% mometasone. The use of this triple combination in patients with melasma has seen a sharp rise over the last few years and with this rampant use the side-effect profile of this triple combination has also come to the fore. <b>Aim</b> : The aim of the present study was to assess the overall safety of the mometasone-based triple combination treatment in the management of melasma. <b>Materials and Methods:</b> This retrospective study was performed on 60 patients of melasma who had used a mometasone-based triple combination treatment for at least 3 weeks anytime in the previous 1 year. The patients were given a preformed questionnaire wherein they assessed the overall effect of the triple combination treatment on their melasma during its use as well as after its withdrawal. The patients were specifically asked about the status of their disease as well as the sun sensitivity of their skin before and after the use of triple combination treatment. In addition, the patients were assessed by a single trained dermatologist for the presence of any adverse effects arising out of the triple combination treatment in the form of telangiectasia, hypertrichosis, acne, skin atrophy, etc. <b>Results:</b> Majority of patients (51.7%) had used the combination treatment well beyond the recommended duration. About one-third (36.7%) of the patients rated their melasma as worse at the time of filling the questionnaire as compared with their disease before the use of triple combination treatment. On clinical examination, the evidence of steroid side effects was seen in 26 patients (43.3%). Steroid-induced telangiectasia was the commonest finding, seen in all of these 26 patients. Steroid-induced skin atrophy, hypertrichosis, and acneiform eruption were seen in 19, 17, and 11 patients, respectively. <b>Conclusions:</b> The propensity of a mometasone-based triple combination treatment to cause steroid adverse effects on the facial skin should always be borne in mind when the same is prescribed as a treatment option in melasma.<br>" @default.
• W2014769241 created "2016-06-24" @default.
• W2014769241 creator A5075620141 @default.
• W2014769241 date "2010-01-01" @default.
• W2014769241 modified "2023-09-26" @default.
• W2014769241 title "Mometasone-based triple combination therapy in melasma: Is it really safe?" @default.
• W2014769241 cites W169222500 @default.
• W2014769241 cites W1984394301 @default.
• W2014769241 cites W1986669980 @default.
• W2014769241 cites W1996827809 @default.
• W2014769241 cites W2003805439 @default.
• W2014769241 cites W2012261088 @default.
• W2014769241 cites W2024652279 @default.
• W2014769241 cites W2049853929 @default.
• W2014769241 cites W2055984976 @default.
• W2014769241 cites W2091844906 @default.
• W2014769241 cites W2100781016 @default.
• W2014769241 cites W2122423912 @default.
• W2014769241 cites W2147602928 @default.
• W2014769241 doi "https://doi.org/10.4103/0019-5154.74545" @default.
• W2014769241 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3051297" @default.
• W2014769241 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21430890" @default.
• W2014769241 hasPublicationYear "2010" @default.
• W2014769241 type Work @default.
• W2014769241 sameAs 2014769241 @default.
• W2014769241 citedByCount "24" @default.
• W2014769241 countsByYear W20147692412012 @default.
• W2014769241 countsByYear W20147692412013 @default.
• W2014769241 countsByYear W20147692412014 @default.
• W2014769241 countsByYear W20147692412015 @default.
• W2014769241 countsByYear W20147692412016 @default.
• W2014769241 countsByYear W20147692412017 @default.
• W2014769241 countsByYear W20147692412019 @default.
• W2014769241 countsByYear W20147692412020 @default.
• W2014769241 countsByYear W20147692412021 @default.
• W2014769241 countsByYear W20147692412022 @default.
• W2014769241 countsByYear W20147692412023 @default.
• W2014769241 crossrefType "journal-article" @default.
• W2014769241 hasAuthorship W2014769241A5075620141 @default.
• W2014769241 hasBestOaLocation W20147692411 @default.
• W2014769241 hasConcept C126322002 @default.
• W2014769241 hasConcept C141071460 @default.
• W2014769241 hasConcept C16005928 @default.
• W2014769241 hasConcept C2776677263 @default.
• W2014769241 hasConcept C2776804153 @default.
• W2014769241 hasConcept C2776999253 @default.
• W2014769241 hasConcept C2777673923 @default.
• W2014769241 hasConcept C2781348165 @default.
• W2014769241 hasConcept C71924100 @default.
• W2014769241 hasConceptScore W2014769241C126322002 @default.
• W2014769241 hasConceptScore W2014769241C141071460 @default.
• W2014769241 hasConceptScore W2014769241C16005928 @default.
• W2014769241 hasConceptScore W2014769241C2776677263 @default.
• W2014769241 hasConceptScore W2014769241C2776804153 @default.
• W2014769241 hasConceptScore W2014769241C2776999253 @default.
• W2014769241 hasConceptScore W2014769241C2777673923 @default.
• W2014769241 hasConceptScore W2014769241C2781348165 @default.
• W2014769241 hasConceptScore W2014769241C71924100 @default.
• W2014769241 hasIssue "4" @default.
• W2014769241 hasLocation W20147692411 @default.
• W2014769241 hasLocation W20147692412 @default.
• W2014769241 hasLocation W20147692413 @default.
• W2014769241 hasLocation W20147692414 @default.
• W2014769241 hasOpenAccess W2014769241 @default.
• W2014769241 hasPrimaryLocation W20147692411 @default.
• W2014769241 hasRelatedWork W1522520075 @default.
• W2014769241 hasRelatedWork W1687284257 @default.
• W2014769241 hasRelatedWork W1966553259 @default.
• W2014769241 hasRelatedWork W1984062094 @default.
• W2014769241 hasRelatedWork W2014769241 @default.
• W2014769241 hasRelatedWork W2071269731 @default.
• W2014769241 hasRelatedWork W2318704377 @default.
• W2014769241 hasRelatedWork W2435105114 @default.
• W2014769241 hasRelatedWork W3214446229 @default.
• W2014769241 hasRelatedWork W2482956694 @default.
• W2014769241 hasVolume "55" @default.
• W2014769241 isParatext "false" @default.
• W2014769241 isRetracted "false" @default.
• W2014769241 magId "2014769241" @default.
• W2014769241 workType "article" @default.